Showing 1 - 5 results of 5 for search 'Marc Lipman', query time: 0.01s Refine Results
  1. 1
    Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK

    Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK by Marc Lipman, Tom Fardon, Roald van der Laan, Joanne Cleverley, Besma Musaddaq, Daniel Peckham, Paul Whitaker, Jacqui White

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis.

    The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis. by Simon Blankley, Christine M Graham, Jacob Turner, Matthew P R Berry, Chloe I Bloom, Zhaohui Xu, Virginia Pascual, Jacques Banchereau, Damien Chaussabel, Ronan Breen, George Santis, Derek M Blankenship, Marc Lipman, Anne O'Garra

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy.

    Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. by Chloe I Bloom, Christine M Graham, Matthew P R Berry, Katalin A Wilkinson, Tolu Oni, Fotini Rozakeas, Zhaohui Xu, Jose Rossello-Urgell, Damien Chaussabel, Jacques Banchereau, Virginia Pascual, Marc Lipman, Robert J Wilkinson, Anne O'Garra

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Randomised controlled trial to evaluate the effectiveness of using the RD-1-based C-Tb skin test as a replacement for blood-based interferon-γ release assay for detection of, and initiation of preventive treatment for, tuberculosis infection: RID-TB:Dx study protocol

    Randomised controlled trial to evaluate the effectiveness of using the RD-1-based C-Tb skin test as a replacement for blood-based interferon-γ release assay for detection of, and i... by Marc Lipman, Ibrahim Abubakar, Chris Griffiths, Penny Whiting, Robert Horne, Alex Ghanouni, Heinke Kunst, Mike Mandelbaum, Molebogeng X Rangaka, Karen Sanders, Peter J White, Angela Crook, Dominik Zenner, Trinh Duong, Vanessa Hack, Julian Surey, Yohhei Hamada, Henry Bern, Joanna Calvert, Marie Francis, Amy Louise Clarke, Ellen Owen-Powell, Helen L Booth

    Published 2021-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.

    Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. by Chloe I Bloom, Christine M Graham, Matthew P R Berry, Fotini Rozakeas, Paul S Redford, Yuanyuan Wang, Zhaohui Xu, Katalin A Wilkinson, Robert J Wilkinson, Yvonne Kendrick, Gilles Devouassoux, Tristan Ferry, Makoto Miyara, Diane Bouvry, Dominique Valeyre, Guy Gorochov, Derek Blankenship, Mitra Saadatian, Phillip Vanhems, Huw Beynon, Rama Vancheeswaran, Melissa Wickremasinghe, Damien Chaussabel, Jacques Banchereau, Virginia Pascual, Ling-Pei Ho, Marc Lipman, Anne O'Garra

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: